Xu J - Search Results

1

Synthesis and evaluation of N-heteroaromatic ring-based analogs of piperlongumine as potent anticancer agents.

Zou Y, Yan C, Zhang H, Xu J, Zhang D, Huang Z, Zhang Y. Zou Y, et al. Among authors: xu j. Eur J Med Chem. 2017 Sep 29;138:313-319. doi: 10.1016/j.ejmech.2017.06.046. Epub 2017 Jun 27. Eur J Med Chem. 2017. PMID: 28686911

2

Synthesis and cytotoxic activity of 17-carboxylic acid modified 23-hydroxy betulinic acid ester derivatives.

Bi Y, Xu J, Wu X, Ye W, Yuan S, Zhang L. Bi Y, et al. Among authors: xu j. Bioorg Med Chem Lett. 2007 Mar 1;17(5):1475-8. doi: 10.1016/j.bmcl.2006.09.096. Epub 2006 Oct 4. Bioorg Med Chem Lett. 2007. PMID: 17275295

3

Synthesis and biological evaluation of novel 1-O- and 14-O-derivatives of oridonin as potential anticancer drug candidates.

Xu J, Yang J, Ran Q, Wang L, Liu J, Wang Z, Wu X, Hua W, Yuan S, Zhang L, Shen M, Ding Y. Xu J, et al. Bioorg Med Chem Lett. 2008 Aug 15;18(16):4741-4. doi: 10.1016/j.bmcl.2008.06.097. Epub 2008 Jul 3. Bioorg Med Chem Lett. 2008. PMID: 18644718

4

Terpenoids. III: Synthesis and biological evaluation of 23-hydroxybetulinic acid derivatives as novel inhibitors of glycogen phosphorylase.

Zhu P, Bi Y, Xu J, Li Z, Liu J, Zhang L, Ye W, Wu X. Zhu P, et al. Among authors: xu j. Bioorg Med Chem Lett. 2009 Dec 15;19(24):6966-9. doi: 10.1016/j.bmcl.2009.10.055. Epub 2009 Nov 2. Bioorg Med Chem Lett. 2009. PMID: 19889536

5

The conversion of oridonin to spirolactone-type or enmein-type diterpenoid: synthesis and biological evaluation of ent-6,7-seco-oridonin derivatives as novel potential anticancer agents.

Wang L, Li D, Xu S, Cai H, Yao H, Zhang Y, Jiang J, Xu J. Wang L, et al. Among authors: xu s, xu j. Eur J Med Chem. 2012 Jun;52:242-50. doi: 10.1016/j.ejmech.2012.03.024. Epub 2012 Mar 23. Eur J Med Chem. 2012. PMID: 22483090

6

Synthesis and biological evaluation of novel furozan-based nitric oxide-releasing derivatives of oridonin as potential anti-tumor agents.

Li D, Wang L, Cai H, Zhang Y, Xu J. Li D, et al. Among authors: xu j. Molecules. 2012 Jun 18;17(6):7556-68. doi: 10.3390/molecules17067556. Molecules. 2012. PMID: 22710829 Free PMC article.

7

Synthesis and biological evaluation of 4'-[(benzimidazole-1-yl)methyl]biphenyl-2-sulfonamide derivatives as dual angiotensin II/endothelin A receptor antagonists.

Bai R, Wei Z, Liu J, Xie W, Yao H, Wu X, Jiang J, Wang Q, Xu J. Bai R, et al. Among authors: xu j. Bioorg Med Chem. 2012 Aug 1;20(15):4661-7. doi: 10.1016/j.bmc.2012.06.011. Epub 2012 Jun 15. Bioorg Med Chem. 2012. PMID: 22750010

8

Studies on the enantiomers of ZJM-289: synthesis and biological evaluation of antiplatelet, antithrombotic and neuroprotective activities.

Wang X, Zhao Q, Wang X, Li T, Lai Y, Peng S, Ji H, Xu J, Zhang Y. Wang X, et al. Among authors: xu j. Org Biomol Chem. 2012 Dec 7;10(45):9030-40. doi: 10.1039/c2ob26511g. Epub 2012 Oct 18. Org Biomol Chem. 2012. PMID: 23076046

9

Synthesis and biological activity of 28-amide derivatives of 23-hydroxy betulinic Acid as antitumor agent candidates.

Bi Y, Xu J, Sun F, Wu X, Ye W, Sun Y, Huang W. Bi Y, et al. Among authors: xu j. Med Chem. 2013 Nov;9(7):920-5. doi: 10.2174/1573406411309070005. Med Chem. 2013. PMID: 23083117

10

Novel nitric oxide-releasing isochroman-4-one derivatives: Synthesis and evaluation of antihypertensive activity.

Bai R, Yang X, Zhu Y, Zhou Z, Xie W, Yao H, Jiang J, Liu J, Shen M, Wu X, Xu J. Bai R, et al. Among authors: xu j. Bioorg Med Chem. 2012 Dec 1;20(23):6848-55. doi: 10.1016/j.bmc.2012.09.043. Epub 2012 Sep 28. Bioorg Med Chem. 2012. PMID: 23084434

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67,302 results

Search Page

Filters